Skip to Main Content

Paper Details

PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
Cell Stem Cell
237
2018
CH, Cell lines, Clonal hematopoiesis, Mg2+, Mn2+, PPM1D, PPM1D mutations, acute myeloid leukemia, cisplatin, doxorubicin, heterozygous mutant Ppm1d hematopoietic cells, malignancy, myelodysplastic syndrome, normal cells, patients, protein phosphatase Mn2+/Mg2+-dependent 1D, stem cell, stem cell clones, wild-type counterparts
Author NameAffiliation
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Timothy P HeffernanCenter for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center
Christopher A BristowCenter for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center
Christopher A BristowCenter for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center
Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center
Hagop KantarjianThe University of Texas MD Anderson Cancer Center
Phillip A FutrealThe University of Texas MD Anderson Cancer Center
Lawrence A DonehowerBaylor College of Medicine
  • 1 - 9

Datasets

Release 1.2